Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–5 of 5 results
Advanced filters: Author: "J. Keith Joung" Clear advanced filters
  • Transcription activator-like effector nucleases (TALENs) comprise a nonspecific nuclease fused to a sequence-specific DNA-binding domain. This domain can be engineered so that TALENs can target virtually any sequence. TALENs are an efficient tool to modify genes in a wide range of cell types and organisms.

    • J. Keith Joung
    • Jeffry D. Sander
    Reviews
    Nature Reviews Molecular Cell Biology
    Volume: 14, P: 49-55
  • Eric Lander, Françoise Baylis, Feng Zhang, Emmanuelle Charpentier, Paul Berg and specialists from seven countries call for an international governance framework.

    • Eric S. Lander
    • Françoise Baylis
    • Ernst-Ludwig Winnacker
    Comments & Opinion
    Nature
    Volume: 567, P: 165-168
  • Synthetic biology approaches to characterize gene regulation have largely used transcription factor circuits in bacteria. However, the multilayered regulation of genes by chromatin in eukaryotes provides opportunities for more sophisticated control of gene expression. This Review describes diverse approaches for engineering eukaryotic chromatin states, the insights gained into physiological gene regulation principles, and the broad potential applications throughout biomedical research and industry.

    • Albert J. Keung
    • J. Keith Joung
    • James J. Collins
    Reviews
    Nature Reviews Genetics
    Volume: 16, P: 159-171
  • Applying CRISPR–Cas9 genome editing technologies in safe and reliable ways requires a firm appreciation of the specificity of target-site recognition and cleavage. In this Review the authors discuss various approaches for characterizing off-target effects of CRISPR–Cas9 genome editing, how mechanistic knowledge can drive the engineering of more-specific nucleases, and the implications for research and therapeutic applications.

    • Shengdar Q. Tsai
    • J. Keith Joung
    Reviews
    Nature Reviews Genetics
    Volume: 17, P: 300-312